These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 4571525)
21. Comparison of heparin and streptokinase in the treatment of venous thrombosis. Porter JM; Seaman AJ; Common HH; Rösch J; Eidemiller LR; Calhoun AD Am Surg; 1975 Sep; 41(9):511-19. PubMed ID: 1101755 [TBL] [Abstract][Full Text] [Related]
22. Venous thromboses in myocardial infarction. Comparison in heparin dosage. Habersberger PG; Pitt A; Anderson ST Br Heart J; 1973 May; 35(5):538-42. PubMed ID: 4716014 [No Abstract] [Full Text] [Related]
23. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992 [TBL] [Abstract][Full Text] [Related]
24. 125I fibrinogen and the prevention of venous thrombosis. Hume M; Kuriakose TX; Zuch L; Turner RH Arch Surg; 1973 Nov; 107(5):803-6. PubMed ID: 4744294 [No Abstract] [Full Text] [Related]
25. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. Hull R; Hirsh J; Jay R; Carter C; England C; Gent M; Turpie AG; McLoughlin D; Dodd P; Thomas M; Raskob G; Ockelford P N Engl J Med; 1982 Dec; 307(27):1676-81. PubMed ID: 6755255 [TBL] [Abstract][Full Text] [Related]
26. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Warlow C; Terry G; Kenmure AC; Beattie AG; Ogston D; Douglas AS Lancet; 1973 Oct; 2(7835):934-6. PubMed ID: 4126560 [No Abstract] [Full Text] [Related]
28. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144 [TBL] [Abstract][Full Text] [Related]
29. Management of acute deep venous thrombosis. Satiani B Am Fam Physician; 1982 Apr; 25(4):103-9. PubMed ID: 7064760 [No Abstract] [Full Text] [Related]
31. Effect of low-dose heparin on incidence of postoperative thrombosis in orthopaedic patients. Abraham-Inpijn L; Vreeken J Arch Chir Neerl; 1975; 27(1):63-8. PubMed ID: 1098580 [TBL] [Abstract][Full Text] [Related]
32. Subcutaneous heparin. A logical prophylaxis for deep vein thrombosis after myocardial infarction. Marks P; Teather D Practitioner; 1978 Mar; 220(1317):425-7. PubMed ID: 643788 [No Abstract] [Full Text] [Related]
33. Current concepts of warfarin therapy. Peterson CE; Kwaan HC Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725 [TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of anticoagulant oral treatment in patients with thrombus in left ventricle after acute myocardial infarction]. Carrillo AM; Valdespino A; Solorio S; Badui E; Enciso R; Lepe L; Lara A; Ocampo S; Alonso R; Romero MA Arch Inst Cardiol Mex; 1997; 67(3):217-22. PubMed ID: 9412434 [TBL] [Abstract][Full Text] [Related]
35. Low dose heparin in the prevention of deep-vein thromboses in patients with acute myocardial infarction. Pitt A; Anderson ST; Habersberger PG; Rosengarten DS Am Heart J; 1980 May; 99(5):574-8. PubMed ID: 7369096 [TBL] [Abstract][Full Text] [Related]